Search Results
Highlights in multiple myeloma: improving access to CAR-T therapy, novel targets & future outlooks
CAR-T therapy in multiple myeloma: recent updates, clinical trials and future outlooks
MYELOMA UNIVERSITY | The patient journey and CAR-T therapy management in multiple myeloma.
Optimizing CAR-T therapy for patients with multiple myeloma in the real-world
Challenges in access to commercial CAR-T therapies in multiple myeloma
CAR T-cells in Multiple Myeloma
Highlights at ASH 2022: the promise of T-cell redirecting therapies in multiple myeloma
Clinical outcomes of patients with R/R multiple myeloma listed for treatment with CAR-T therapy
Can a patient use a different CAR-T target after receiving BCMA directed therapy?
What are the main improvements in next-generation CAR T-cell products?
The potential of CS1-targeted CAR-T therapy in multiple myeloma
CAR-T therapy options for multiple myeloma
